https://www.selleckchem.com/pr....oducts/bgb-283-bgb28
There were no differences between patients treated by early (first week) versus late (after the first week) ERCP regarding the needed interventions, type of PCBI, type and diameter of the inserted stents, and the overall success. There were no adverse events associated with ERCP management. ERCP was valuable in the treatment of 88.46% of injured cases. There were no differences between early and late ERCP in the treatment of PCBI. Furthermore, ERCP management was not associated with adverse events. ERCP was valuable in the treatm
Beğen
Yorum Yap
Paylaş
